Trial Profile
Clinical Trials Insight: 700032656
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 17 Apr 2008
Price :
$35
*
At a glance
- Drugs JNJ 26854165 (Primary)
- Indications Non-small cell lung cancer; Prostate cancer
- Focus Adverse reactions
- 17 Apr 2008 New trial record.